Tarlatamab for Previously Treated Small-Cell Lung Cancer

Tarlatamab showed promising activity and safety in a phase 2 study.

Saved in:
Bibliographic Details
Published inNEJM journal watch. Oncology & hematology
Main Author Patel, Jyoti D
Format Journal Article
LanguageEnglish
Published Waltham Massachusetts Medical Society 15.11.2023
Subjects
Lung cancer
Online AccessGet full text

Cover

More Information
Summary:Tarlatamab showed promising activity and safety in a phase 2 study.
ISSN:2330-0426